IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Log in (now much improved!)

Citations for "The economic control of infectious diseases"

by Gersovitz, Mark & Hammer, Jeffrey S.

For a complete description of this item, click here. For a RSS feed for citations of this item, click here.
as
in new window


  1. Rikard Forslid & Mathias Herzing, 2015. "On the Optimal Production Capacity for Influenza Vaccine," Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 726-741, 06.
  2. Marlène Guillon & Josselin Thuilliez, 2015. "HIV and Rational risky behaviors: a systematic review of published empirical literature (1990-2013)," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-01222571, HAL.
  3. repec:eee:eecrev:v:94:y:2017:i:c:p:23-44 is not listed on IDEAS
  4. Herrmann, Markus & Gaudet, Gérard, 2009. "The economic dynamics of antibiotic efficacy under open access," Journal of Environmental Economics and Management, Elsevier, vol. 57(3), pages 334-350, May.
  5. Javier Birchenall, 2007. "Escaping high mortality," Journal of Economic Growth, Springer, vol. 12(4), pages 351-387, December.
  6. Chris Papageorgiou & Petia Stoytcheva, 2005. "What Do We Know About the Impact of AIDS on Cross-Country Income So Far?," Departmental Working Papers 2005-01, Department of Economics, Louisiana State University.
  7. Vyas, Sangita & Kov, Phyrum & Smets, Susanna & Spears, Dean, 2016. "Disease externalities and net nutrition: Evidence from changes in sanitation and child height in Cambodia, 2005–2010," Economics & Human Biology, Elsevier, vol. 23(C), pages 235-245.
  8. Barrett, Scott & Hoel, Michael, 2007. "Optimal disease eradication," Environment and Development Economics, Cambridge University Press, vol. 12(05), pages 627-652, October.
  9. Anderson, Soren T. & Laxminarayan, Ramanan & Salant, Stephen W., 2012. "Diversify or focus? Spending to combat infectious diseases when budgets are tight," Journal of Health Economics, Elsevier, vol. 31(4), pages 658-675.
  10. Aadland David & Finnoff David C. & Huang Kevin X.D., 2013. "Syphilis Cycles," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 14(1), pages 297-348, June.
  11. Mesnard, Alice & Seabright, Paul, 2008. "Migration and The Equilibrium Prevalence of Infectious Diseases," CEPR Discussion Papers 6651, C.E.P.R. Discussion Papers.
  12. Stefano Bosi & David Desmarchelier, 2016. "Pollution and infectious diseases," Working Papers 2016.22, FAERE - French Association of Environmental and Resource Economists.
  13. Douglas Gollin & Christian Zimmermann, 2005. "Malaria," 2005 Meeting Papers 561, Society for Economic Dynamics.
  14. Herrmann, Markus, 2010. "Monopoly pricing of an antibiotic subject to bacterial resistance," Journal of Health Economics, Elsevier, vol. 29(1), pages 137-150, January.
  15. Stéphane Mechoulan, 2007. "Market structure and communicable diseases," Canadian Journal of Economics, Canadian Economics Association, vol. 40(2), pages 468-492, May.
  16. Park, Hojeong, 2016. "A real option analysis for stochastic disease control and vaccine stockpile policy: An application to H1N1 in Korea," Economic Modelling, Elsevier, vol. 53(C), pages 187-194.
  17. Goyal, Sanjeev & Vigier, Adrien, 2015. "Interaction, protection and epidemics," Journal of Public Economics, Elsevier, vol. 125(C), pages 64-69.
  18. Aditya Goenka & Lin Liu, 2012. "Infectious diseases and endogenous fluctuations," Economic Theory, Springer;Society for the Advancement of Economic Theory (SAET), vol. 50(1), pages 125-149, May.
  19. Chanel, Olivier & Luchini, Stéphane & Massoni, Sébastien & Vergnaud, Jean-Christophe, 2011. "Impact of information on intentions to vaccinate in a potential epidemic: Swine-origin Influenza A (H1N1)," Social Science & Medicine, Elsevier, vol. 72(2), pages 142-148, January.
  20. Rowthorn, Robert & Toxvaerd, Flavio, 2012. "The Optimal Control of Infectious Diseases via Prevention and Treatment," CEPR Discussion Papers 8925, C.E.P.R. Discussion Papers.
  21. Mesnard, Alice & Seabright, Paul, 2008. "Escaping Epidemics Through Migration? Quarantine Measures under Asymmetric Information about Infection Risk," IDEI Working Papers 521, Institut d'Économie Industrielle (IDEI), Toulouse.
  22. repec:hal:wpaper:halshs-01222571 is not listed on IDEAS
  23. Toxvaerd, Flavio, 2010. "Recurrent Infection and Externalities in Prevention," CEPR Discussion Papers 8112, C.E.P.R. Discussion Papers.
  24. Thomas Colignatus, 2004. "Modifying behaviour on STI including HIV and oncogenic HPV: a draft protocol for a registry open to the registered subject, generating the concept of a 'STI passport'," HEW 0412001, EconWPA.
  25. Costello, Christopher & Quérou, Nicolas & Tomini, Agnes, 2017. "Private eradication of mobile public bads," European Economic Review, Elsevier, vol. 94(C), pages 23-44.
  26. Berthélemy, Jean-Claude & Gaudart, Jean & Thuilliez, Josselin, 2015. "Prevention or treatment? The case of malaria," Economics Letters, Elsevier, vol. 131(C), pages 16-19.
  27. Sims, Charles & Finnoff, David & O’Regan, Suzanne M., 2016. "Public control of rational and unpredictable epidemics," Journal of Economic Behavior & Organization, Elsevier, vol. 132(PB), pages 161-176.
  28. Casper Worm Hansen & Peter Sandholt Jensen & Peter Egedesø Madsen, 2017. "Preventing the White Death: Tuberculosis Dispensaries," Discussion Papers 17-19, University of Copenhagen. Department of Economics.
  29. M. Ceddia, 2012. "Optimal Disease Eradication in Sympatric Metapopulations," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 52(4), pages 499-530, August.
  30. Fenichel, Eli P., 2013. "Economic considerations for social distancing and behavioral based policies during an epidemic," Journal of Health Economics, Elsevier, vol. 32(2), pages 440-451.
  31. Goenka, Aditya & Liu, Lin & Nguyen, Manh-Hung, 2014. "Infectious diseases and economic growth," Journal of Mathematical Economics, Elsevier, vol. 50(C), pages 34-53.
  32. Casper Worm Hansen & Peter Sandholt Jensen & Peter Egedesø Madsen, 2016. "Information and Disease Prevention: Tuberculosis Dispensaries," Discussion Papers 16-01, University of Copenhagen. Department of Economics.
  33. Momota, Akira & Tabata, Ken & Futagami, Koichi, 2005. "Infectious disease and preventive behavior in an overlapping generations model," Journal of Economic Dynamics and Control, Elsevier, vol. 29(10), pages 1673-1700, October.
  34. Na Hao & Gervan Fearon, 2009. "Government Funding Policy Towards Communicable Diseases," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 37(2), pages 121-134, June.
  35. Brahmbhatt, Milan & Dutta, Arindam, 2008. "On SARS type economic effects during infectious disease outbreaks," Policy Research Working Paper Series 4466, The World Bank.
  36. Gersovitz, Mark & Hammer, Jeffrey S., 2005. "Tax/subsidy policies toward vector-borne infectious diseases," Journal of Public Economics, Elsevier, vol. 89(4), pages 647-674, April.
  37. Azomahou, Theophile & Soete, Luc & Diene, Bity & Diene, Mbaye, 2012. "Optimal health investment with separable and non-separable preferences," MERIT Working Papers 047, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  38. repec:hal:wpaper:halshs-00543967 is not listed on IDEAS
  39. Goyal, Sanjeev & Vigier, Adrien, 2015. "Interaction, protection and epidemics," Journal of Public Economics, Elsevier, vol. 125(C), pages 64-69.
  40. José García-Montalvo & Marta Reynal-Querol, 2002. "Fighting Against Malaria: Prevent Wars While Waiting For The "Miraculous" Vaccine," Working Papers. Serie EC 2002-31, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
  41. Terrence August & Tunay I. Tunca, 2006. "Network Software Security and User Incentives," Management Science, INFORMS, vol. 52(11), pages 1703-1720, November.
  42. Telalagic, S., 2012. "Optimal Treatment of an SIS Disease with Two Strains," Cambridge Working Papers in Economics 1229, Faculty of Economics, University of Cambridge.
  43. Horan, Richard D. & Fenichel, Eli P. & Finnoff, David & Wolf, Christopher A., 2015. "Managing dynamic epidemiological risks through trade," Journal of Economic Dynamics and Control, Elsevier, vol. 53(C), pages 192-207.
  44. Marcello Basili & Filippo Belloc, 2012. "How to Measure the Economic Impact of Vector-Borne Diseases at a Country Level: An Assessment," Department of Economics University of Siena 648, Department of Economics, University of Siena.
This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.